Gabriel Haering, CEO of API manufacturer Cerbios, highlights the importance of "Swiss-ness" to the company's brand, their attentiveness to diversification and scaling the value chain, and the future prospects for Swiss CMOs.
Cerbios is renowned for its expertise in the process development and contract manufacturing of Active Pharmaceutical Ingredients (APIs) and in particular High Potency Active Ingredients (HPAIs). Could you please begin by introducing how the company initially came about and the scope of its operations today?
"As a company, we always have one eye looking towards the future so as to remain at the forefront of the technological curve and a step ahead of our competitors."
